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Summary: Based on immunoassay by particle counting, three methods for antithrombin III, von Willebrand
factor and plasminogen were developed on an automated IMPACT® machine and on a semi-automated
MULTIPACT® System. Precision of the techniques, measured at low, medium and high level of the calibration
curve showed coefficients of Variation varying from 4.3 to 13.8%. Accuracy was evaluated by dilution recovery
test and by correlation with rocket immunoelectrophoresis and chromogenic Substrate techniques. The results
show that the proposed methods correlate well with existing techniques and that immunoassay by particle
counting is applicable to several coagulation tests.
qc-fetoprotein (2), ferritin (3), IgE (4), or for small
Immunoassay by particle counting is based on latex molecules like digoxin (5), and also for antibodies (6,
particle agglutination, where the extent of the reaetion 7) aiid immune complexes (8).
is measured by counting the remaining number of ._, , . f. . / - . , . . , ' ' We present here three convement immunoassays fornon-agglutmated particles m a particle counter de- - -f A . . r .^ , . TTT „,.,, , ,fT i- -L · χ ^, A. , the determmation of antithrombin III, von Willebrandsigned for hght scattenng measurements. The particles ,. . , , ^, .j ' . . τ-/ i«\/ £· * r Λ j- factor antigen and plasminogen. The three assayscoated with F(ab)2 fragments of antibodies are ag- , . , &. . · . °r , - . ,Λ . ., . , t - ^ * 4 . , A, . , have mcubation times varying from 15 to 60 mmutesglutmable by the antigens to be measured: the number ~ ~ , . - . β . ,. ,• f > . * · , - - i and are performed either m an automatic mode onof remaining free particles, or monomers, is inversely τχ^πΑ^τί» u- /A Λ τν *· c o^^o, * . .. * J the IMPACT® machine (Acade Diagnostic Systems,proportional to the antigen concentration. T . . ... Ώ ι · \ · * ^^K * - - Louvam4a-Neuve, Belgium) or in a semi-automatic
This technique, previously called Particle Counting mode using the modular new high throughput MUL-
Immunoassay, h s been reviewed elsewhere (1). Ap- TIPACT® System (Acade Diagnostic Systems, Lou-
plications were developed for large antigens such s vain-la-Neuve, Belgium). Both Systems operate on the
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same principle and have the same incubation medium;
they differ in reaction volumes, incubation time and
in the handling of reagents and samples. The perform-
ances of these methods were compared with classical




Estapor Kl50 0.8 latex particles were from Rhone-Poulenc
(Courbevoie, France).
Bovine serum albumin, Fraction V was from the Biochemical
Corporation (Cleveland, USA) and human transferrin from
Behringwerke AG (Marburg/Lahn, FRG).
Anti-vWF:Ag and anti-plasminogen antibodies were obtained
from DAKO (Dakopatts, Sweden) äs IgG Solutions.
Anti-antithrornbin III antiserum was purchased from Behring^
werke AG Marburg/Lahn, FRG).
"Glycine-buffered saline" was 0.1 mol/1 glycine, 0.17 mol/1 NaCl
and contained 40 mg of sodium azide per litre; the pH was
adjusted to 9.2 with NaOH.
• \
Glycine buffered saline/bovine serum albumin l g/l and glycine
buffered saline/bovine serum albumin 10 g/l were glycine-buff-
ered saline containing respectively l g and 10g bovine serum
albumin per litre.
Glycine buffered saline transferrin was glycine buffered saline
containing l g/l transferrin (Behringwerke, Marburg/Lahn,
FRG).
Glycine buffered saline Tween was glycine-buffered saline con-
taining 0.2 ml of Tween® 20 (Technicon Instruments, Corp.,
Tarrytown, USA) per litre.
Isolation of IgG from antiserum
IgG of the rabbit anti-antithrombin III were affinity-purified
on a Protein A-Sepharose column (Pharmacia, Uppsala, Swe-
den). After adsorption in neutral conditions, the IgG were
eluted with 0.1 mol/1 glycine-HCl pH 3 buffer containing 0.5
mol/1 NaCl, precipitated in 50% saturated ammonium sulphate,
redissolved and dialysed against saline.
Preparation of F(ab)'2 fragments of IgG
F(ab)'2 fragments of the rabbit IgG, anti-antithrombin III, anti-
vWF:Ag and anti-plasminogen were prepared äs described in
I.e. (2).
Coupling of F(ab)'2 fragments to latex particles
Carboxylated latex particles were covalently coated with the
different F(ab)'2 fragments äs described previously (9). The
protein/latex weight ratios were respectively 1/50 for the an-
tithrombin III assay, 1/100 for the vW.F:Ag and the plasmin-
ogen assays.
The coated latexes were suspended at concentrations of 0.5 g/l
in glycine buffered saline containing l g/l bovine serum albumin
for the vWF:Ag and plasminogen assay, and in glycine buffered
saline containing l g/l of transferrin for the antithrornbin III
assay. For long term storage these suspensions were kept at
—20 °C or were freeze-dried.
Automated procecure,s
The automated assays were performed on the IMPACT® in-
strument. This apparatus consists of a thermostated vortexing
tray for samples and reaction tubes, and four automatic pipet-
ting-diluting stations. This module is connected with the optical
bench of the particle counter via a continuous fl'ow manifold
operated by a peristaltic pump. All Operation controls and data
treatments are performed with a desk^top Computer; counting
results are expressed äs peak heights. . f
The IMPACT® was used according to the specifications of the
manufacturer.
Table l shows the assay characteristics of the three automated
assays. After an off-line dilution Step, samples are further di*
luted in the machine; 30 of diluted sample are then rhixed
with 30 of activated latex particles in a reaction tube, followed
by incubation for 30 minutes at 37 °C. Reactions are stopped
by dilution of the reaction mixture. An aliquot of latex suspen*
sions is then further diluted in the manifold and passes through
the flow cell for optical measurement of the remaining mono-
mers of latex particles. The thrpughput is 60 samples/hour.
Single determinations were performed.
Semi-automated assay procedufes
The semi-automated assays were perfprmed using the MUL-
TIPACT® agitating and counting modules. After a predilution
step, the samples were dispensed into l ml polystyrene tubes
on a 48-position rack and mixed with latex reagerits in the
thermostated vortexing agitator.
The reactions were stopped by diluting the particles with glycine
buffered saline containing 0.1 mol/1 EDTA and the reaction
tubes were placed in the counting module. The throughput is
180 samples/hour. Single determinations were performed.
The system was used according to the specifications of the
manufacturer.
Table 2 summarizes the assay characteristics of the semi-auto-
mated methods.
Comparison methods
Chromogenic Substrate kits, Coatest® S-2251 for plasminogen
and S-2238 for antithrombin III, were from Kabi Vitrum AB
(Mölndal, Sweden). Rocket immunoelectrophoresis was per-
formed äs described by Laurell (10).
Standards and control
A pool of fresh plasma from 12 healthy donnors was calibrated
with the Reference Plasma 100% obtained from immuno AG
(Vienna, Austria). The antigen concentrations were 1:5 mg/1
for antithrombin III, 7 mg/1 for" vWF:Ag and 0.2 mg/1 for
plasminogen. For convenience and in conformity with usual
practice, Standards were expressed in % (11). The pool of
plasma was diluted to prepare 400%, 200%, 100%, 50%, 25%,
12.5% and 6.25% Standards (tab. 3).
For antithrombin III, the pool of plasriia was diluted in glycine
buffered saline/Tween. For vWF:Ag and plasminogen, the pool
of plasma was diluted in glycine buffered saline containing l g/l
bovine serum albumin, while for plasminogen on MÜLTI-
PACT® the plasma had to be diluted in glycerine buffered
saline containing 10 g/l bovine serum albumin.
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a with glycine buffered saline/Tween
b with glycine buffered saline containing l g/l bovine serum albumin
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10 g/l bovine serum albumin









































































Five plasma were serially
dilution buffer, assayed in
























diluted in the appropriate
the MULTIPACT® System,
Calibration curves were constructed by plotting the
peak heights against the log of dilutions of the stand^·
ard plasma, expressed s percentages of the Standard
plasma.
In each case, a sigmo'id l curve was obtained. Both
IMPACT® and MULTIPACT® showed similar cali-
bration curves. The Calibration curves obtained on
the IMPACT® Instrument are shown below (fig. 1).
Linearities
In order to assess the accuracy of the assays, we
performed the dilution reeovery test on each assay.
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Results fof the three assays are reported on table 4.
The first dilutions, reported s 1:1 in table 4, are
related to plasma dilution from table 1.
Precision of the methods
Intra-assay reproducibilities of the three methods
were evaluated for three different levels of the Stand-
ard curve on the MULTIPACT® System (tab. 5). Day
to day variability s assessed by the IMPACT® System
with the Refefence Plasma 100% (Immuno AG), dur-
ing ten days, gave 5.8% for antithrombin III, 5.3%
for vWF:Ag and 4.7% for plasminogen.
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Tab. 4. Dilution recovery lests performed on MULTIPACT®
Plasma dilution


















































































Values are expressed äs % of pool of normal plasma.


















































6.25 12.5 25 50 100
Percent of pool of normal plasmas
200 400
Fig. l Typical calibration curves of the three assays performed






Immunoassays using the IMPACT® System were com-
pared with rocket immunoelectrophoresis (all three
methods), and with chromogenic Substrate techniqües
for antithrombin III and plasminogen (tab. 6). Rocket
immunoelectrophoresis and chromogenic Substrate
methods were performed with citrated plasma, which
was centrifuged and immediately frozen at ^20°C.
No differences were öbserved between assays made
on fresh and frozen samples.
IMPACT® measurements were performed on säinples
stored at —20 °C for one to two weeks.













y = 6.813 + 0.828
r = 0.947
y = 5.920 + 0.874
Measuring ränge


















y = 3.487 + 0,945
r = 0:946
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Discussion
The techniques described in this paper offer several
advantages. First of all, based on latex agglutination
combined with optical measurement, these methods
are non-radioisotopic and homogeneous; no Separa-
tion steps are required during the assays. The ho-
mogeneous System allows automation of the reaction.
With the requirement of a predilution Step, the meth-
ods are completely automated with the IMPACT®
System while the MULTIPACT® presents a conveni-
ent semi-automated System: after hand pipetting of
samples and reagents, the rack of tubes is manually
placed in the agitator module, then transferred to the
optical reader for automatic particle counting. The
IMPACT® System is well adapted for assaying the
same antigen in long series of samples while MUL-
TIPACT® is suitable for measuring different antigens
in smaller numbers of samples. Latex reagents were
usable in both System and sample dilutions had to be
adapted for each System.
We made only one reagent modification, i. e. the di-
lution buffer for plasminogen assay in MULTIPACT®
System: instead of glycine buffered saline containing
l g/l bovine serum albumin, we used glycine buffered
saline containing 10 g/l bovine serum albumin. This
was found to be necessary, owing to the very high
dilutions performed for this assay on the MULTI-
PACT® System. The presence of a fairly high bovine
serum albumin concentration prevented denaturation
or adsorption of plasminogen onto the plastic tubes.
High sample dilutioii is necessary because of the low
threshold of sensitivity (below g/l) of the technique;
although this feature may appear to be a drawback,
it can be overcome by using an automatic diluting
device.
Comparisons of the methods with well established
methods showed good correlations in all cases. Cor-
relation coefficients below 0.9 were obtained with
rocket immunoelectrophoresis for the antithrombin
III and plasminogen assays, but this method is known
to display a poor precision. This observation is con-
firmed by the excellent correlations with the respective
chromogenic Substrate assays. Dilution recovery tests
did not reveal any tendency to overestimation or
underestimation resulting from the plasma predilu-
tion. The good recovery results, together with the
acceptable precision, lead us to believe that immu-
noassay by particle counting has a place in coagula-
tion testing. In the laboratory of one of us (E. Lav-
enne)9 these tests have been routinely performed for
nearly two years and more than 5000 tests have been
performed without problems so far.
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